Diabetic Ketoacidosis Author: Heather Lochnan, MD
Approved for review - 2009-03-25
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Patient Education
  • Educate patients to recognize early signs of DKA.
  • Consider recurrent DKA to be a “red flag.”

Educate patients to recognize early signs of DKA. BC

  • Refer to diabetes center for intensive education.
Background | Back to top


Consider recurrent DKA to be a “red flag.” BC

  • Ensure that patients with recurrent DKA receive support from a multidisciplinary team and have access to a diabetes nurse.
Background | Back to top

FAQs
Ebenezer A. Nyenwe, MD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Heather Lochnan, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for continuing medical education grand rounds and lectures given.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.